| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2015 ( Subtotal = $5,000 ) |
| 2015 | 2015 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R44EY014772 | Non-Invasive Treatment for Uveitis | 000 | 5 | NIH | 5/1/2015 | $5,000 |
|
 | Issue Date FY: 2014 ( Subtotal = $955,724 ) |
| 2014 | 2014 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R44EY014772 | Non-Invasive Treatment for Uveitis | 000 | 5 | NIH | 6/10/2014 | $955,724 |
|
 | Issue Date FY: 2013 ( Subtotal = $1,073,868 ) |
| 2013 | 2013 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R44EY014772 | Non-Invasive Treatment for Uveitis | 000 | 4 | NIH | 4/15/2013 | $1,073,868 |
|
 | Issue Date FY: 2010 ( Subtotal = $1,300,144 ) |
| 2010 | 2010 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R43EY020791 | NOVEL METHOD FOR THE OCULAR IONTOPHORETIC DELIVERY OF AVASTIN AND LUCENTIS | 000 | 1 | NIH | 5/26/2010 | $107,000 |
| 2010 | 2010 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R44EY014772 | Non-Invasive Treatment for Uveitis | 000 | 3 | NIH | 8/26/2010 | $1,086,144 |
| 2010 | 2010 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R43EY020791 | NOVEL METHOD FOR THE OCULAR IONTOPHORETIC DELIVERY OF AVASTIN AND LUCENTIS | 000 | 1 | NIH | 5/26/2010 | $107,000 |
|
 | Issue Date FY: 2009 ( Subtotal = $1,084,901 ) |
| 2009 | 2009 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R44EY014772 | Non-Invasive Treatment for Uveitis | 000 | 2 | NIH | 9/23/2009 | $1,084,901 |
|
 | Issue Date FY: 2004 ( Subtotal = $133,202 ) |
| 2004 | 2004 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R43EY014772 | NON-INVASIVE DRUG DELIVERY TO TREAT POSTERIOR UVEITIS | 000 | 1 | NIH | 8/27/2004 | $133,202 |
|
 | Issue Date FY: 2002 ( Subtotal = $300,501 ) |
| 2002 | 2002 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R43DK059690 | IMPROVED NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE | 000 | 1 | NIH | 9/16/2002 | $140,992 |
| 2002 | 2002 | ACIONT INC | 350 WEST 800 NORTH | SALT LAKE CITY | UT | 84103 | SALT LAKE | USA | R43DK060308 | NON-INVASIVE BLOOD PHENYLALANINE MONITOR | 000 | 1 | NIH | 9/6/2002 | $159,509 |
|
|